Loading...
Arava
DMARD • Pyrimidine synthesis inhibitor
Half-life
15-18 days (active metabolite)
Protein Binding
>99%
Metabolized By
CYP1A2, CYP2C19
External
Drugs.comActive metabolite teriflunomide inhibits dihydroorotate dehydrogenase, blocking pyrimidine synthesis
Drug Class
DMARD
Subclass
Pyrimidine synthesis inhibitor
Half-life
15-18 days (active metabolite)
Time for plasma concentration to decrease by 50%
Protein Binding
>99%
Fraction bound to plasma proteins
Therapeutic Index
Wide
Margin between therapeutic and toxic doses